The present application describes novel uracil derivatives of formula I: A-W-U-X-Y-Z-U.sup.a-X.sup.a-Y.sup.a-Z.sup.aIor pharmaceutically acceptable salt or prodrug forms thereof, wherein A, W, U, X, Y, Z, U.sup.a, X.sup.a, Y.sup.a, and Z.sup.a are defined in the present specification, which are useful as inhibitors of TNF-.alpha. converting enzyme (TACE), matrix metalloproteinases (MMP), aggrecanase or a combination thereof.

 
Web www.patentalert.com

< Anti-idiotypic anti-TNF antibodies and related immunoassay methods

< Modulators of regulatory proteins

> 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof

> TNF-.alpha.variants

~ 00286